These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12846174)

  • 41. Infection rates in HIV-HCV patients treated with interferon are similar to those in HCV mono-infection and not related to neutropenia.
    Cooper CL; Al-Bedwawi S
    HIV Clin Trials; 2006; 7(5):251-4. PubMed ID: 17162319
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response.
    Malnick SD; Basevitch A
    Gastroenterology; 2006 Aug; 131(2):683; author reply 683-4. PubMed ID: 16890628
    [No Abstract]   [Full Text] [Related]  

  • 43. Peginterferon alfa-2a (40KD): a potent long-acting form of interferon alfa-2a for the treatment of hepatitis C.
    Modi MW; Lamb MW; Shiomi M
    Adv Exp Med Biol; 2003; 519():59-67. PubMed ID: 12675208
    [No Abstract]   [Full Text] [Related]  

  • 44. Treatment of hepatitis C in children.
    Aziz S
    J Coll Physicians Surg Pak; 2005 Jun; 15(6):317-8. PubMed ID: 15924831
    [No Abstract]   [Full Text] [Related]  

  • 45. Hepatitis C treatment, HAART and side effects.
    TreatmentUpdate; 2001; 13(7):7-8. PubMed ID: 11794865
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment strategies of acute and chronic hepatitis C].
    Gładysz A; Inglot M
    Przegl Epidemiol; 2002; 56 Suppl 5():10-5. PubMed ID: 15553066
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Drug therapy of hepatitis B and C].
    Färkkilä M
    Duodecim; 2003; 119(6):519-29. PubMed ID: 12708339
    [No Abstract]   [Full Text] [Related]  

  • 48. Focus on hepatitis. Weight-based versus fixed-dose peginterferons.
    Shaw-Stiffel T
    IAPAC Mon; 2004 May; 10(5):178-80. PubMed ID: 15366103
    [No Abstract]   [Full Text] [Related]  

  • 49. Interferon for hepatitis C patients with psychiatric disorders.
    Asnis GM; De La Garza R; Rego SA; Henderson MA; Reinus JF
    Am J Psychiatry; 2004 Dec; 161(12):2332; author reply 2332-4. PubMed ID: 15569920
    [No Abstract]   [Full Text] [Related]  

  • 50. Acquired factor VIII inhibitor in an HIV-infected patient after treatment with pegylated interferon-alpha 2a and ribavirin.
    Paul S; Javed U; Tevendale R; Lanford J; Liu R
    AIDS; 2007 Mar; 21(6):784-5. PubMed ID: 17413709
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of interferon alfa-2b and ribavirin treatment on hepatitis C-associated cryoglobulinemia and rheumatoid factor: comment on the article by Vassilopoulos and Calabrese.
    Medhekar S; Nutt A; Raufman JP; Jasin HE
    Arthritis Rheum; 2003 Feb; 48(2):580-1. PubMed ID: 12571874
    [No Abstract]   [Full Text] [Related]  

  • 52. Seventy-two weeks of peginterferon and ribavirin for patients with partial early virologic response?
    Hoefs JC; Morgan TR
    Hepatology; 2007 Dec; 46(6):1671-4. PubMed ID: 18046713
    [No Abstract]   [Full Text] [Related]  

  • 53. Pegylated interferon-alpha for the treatment of sexually transmitted acute hepatitis C in HIV-infected individuals.
    Vogel M; Nattermann J; Baumgarten A; Klausen G; Bieniek B; Schewe K; Jessen H; Boesecke C; Rausch M; Lutz T; Fenske S; Schranzo D; Kümmerle T; Schuler C; Theisen A; Mayr C; Seidel T; Rockstroh JK
    Antivir Ther; 2006; 11(8):1097-101. PubMed ID: 17302380
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Acute hepatitis C virus infection--clinical manifestations, diagnosis and treatment].
    Peters L; Lindhardt BØ
    Ugeskr Laeger; 2006 Oct; 168(42):3601-4. PubMed ID: 17069720
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peginterferon alfa-2b and ribavirin in thalassaemia/chronic hepatitis C virus-co-infected non-responder to standard interferon-based.
    Hamidah A; Thambidorai CR; Jamal R
    Med J Malaysia; 2005 Oct; 60(4):517-9. PubMed ID: 16570722
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pre-emptive treatment of recurrent hepatitis C infection.
    Charlton M
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S50-4. PubMed ID: 12362299
    [No Abstract]   [Full Text] [Related]  

  • 57. Acute viral hepatitis C should be treated.
    Dhiman RK; Chawla Y
    Indian J Gastroenterol; 2005; 24(2):68-71. PubMed ID: 15879654
    [No Abstract]   [Full Text] [Related]  

  • 58. [HIV-naive patients respond to pegylated interferon].
    Internist (Berl); 2003 Jun; 44(6):672. PubMed ID: 14733245
    [No Abstract]   [Full Text] [Related]  

  • 59. Severe cholestasis in a patient with acute hepatitis C treated with interferon alpha-2b.
    Mukherjee S; Gilroy RK; Schafer DF
    Am J Gastroenterol; 2002 Aug; 97(8):2152-3. PubMed ID: 12190203
    [No Abstract]   [Full Text] [Related]  

  • 60. Acute hepatitis C: in search of the optimal approach to cure.
    Craxì A; Licata A
    Hepatology; 2006 Feb; 43(2):221-4. PubMed ID: 16440365
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.